Publications

2019

Ibrahim MM, Gabr MT. Multitarget therapeutic strategies for Alzheimer's disease. Neural Regen Res. 2019;14(3):437-440.
Khosla M, Jamison K, Ngo GH, Kuceyeski A, Sabuncu MR. Machine learning in resting-state fMRI analysis. Magn Reson Imaging. 2019;64:101-121.
Amor-Coarasa A, Kelly JM, Singh PK, Ponnala S, Nikolopoulou A, Williams C, et al. [F]Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR4. Molecules. 2019;24(8).
Melsaether AN, Kim E, Mema E, Babb J, Kim SG. Preliminary study: Breast cancers can be well seen on 3T breast MRI with a half-dose of gadobutrol. Clin Imaging. 2019;58:84-89.
Fossati S, Cejudo JR, Debure L, Pirraglia E, Sone JY, Li Y, et al. Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease. Alzheimers Dement (Amst). 2019;11:483-492.
Zhang S, Chiang GC, Magge RS, Fine HA, Ramakrishna R, Chang EW, et al. Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas. Eur Radiol. 2019;29(6):2751-2759.
O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, et al. Pharmacokinetics and Biodistribution of a [Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients. Mol Pharm. 2019;16(7):3083-3090.
Weidman EK, Schweitzer AD, Niogi SN, Brady EJ, Starikov A, Askin G, et al. Diffusion tensor imaging and quantitative susceptibility mapping as diagnostic tools for motor neuron disorders. Clin Imaging. 2019;53:6-11.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065